Targeting phosphodiesterase 4 as a potential therapeutic strategy for enhancing neuroplasticity following ischemic stroke
PDE4 inhibitors in COPDFa more selective approach to treatment
Otezla Mechanism of Action (MOA) — PDE4 Inhibitor | Otezla® (apremilast) Healthcare Professional Site
DC591017, a phosphodiesterase-4 (PDE4) inhibitor with robust anti-inflammation through regulating PKA-CREB signaling - ScienceDirect
PDE4 Inhibitors and Psoriasis: How Do They Affect You? | MyPsoriasisTeam
Frontiers | Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases
Action of PDE4 inhibitors can prolong or enhance effects of cAMP and... | Download Scientific Diagram
Figure 1 from Apremilast : a novel PDE 4 inhibitor in the treatment of autoimmune and inflammatory diseases | Semantic Scholar
PDE4 subtypes in cancer | Oncogene
Molecules | Free Full-Text | An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022
Inhibition of PDE4B suppresses inflammation by increasing expression of the deubiquitinase CYLD | Nature Communications
Reducing Neuroinflammation in Psychiatric Disorders: Novel Target of Phosphodiesterase 4 (PDE4) and Developing of the PDE4 Inhibitors | IntechOpen
Emerging anti-inflammatory strategies for COPD | European Respiratory Society
Frontiers | Tanimilast, A Novel Inhaled Pde4 Inhibitor for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease
Schematic representation of how Phosphodiesterase 4 (PDE4) inhibitors,... | Download Scientific Diagram
File:Mechanism of action of PDE4 inhibitor.jpg - Wikimedia Commons
Targeting PDE4 as a promising therapeutic strategy in chronic ulcerative colitis through modulating mucosal homeostasis - ScienceDirect
Frontiers | Inhaled Phosphodiesterase 4 (PDE4) Inhibitors for Inflammatory Respiratory Diseases
Phosphodiesterase inhibitor - Wikipedia
Phosphodiesterase-4 (PDE4) inhibitors have the potential to suppress... | Download Scientific Diagram
Phosphodiesterase-4 enzyme as a therapeutic target in neurological disorders - ScienceDirect
Inhibition of PDE4 protects neurons against oxygen-glucose deprivation-induced endoplasmic reticulum stress through activation of the Nrf-2/HO-1 pathway - ScienceDirect
PDE4 inhibition: a novel approach for the treatment of inflammatory bowel disease: Trends in Pharmacological Sciences
R)-(-)-Rolipram, Selective PDE4 inhibitor (CAS 85416-75-7) (ab120031) | Abcam
